The prevention and treatment of missing data in clinical trials
N Engl J Med
.
2012 Oct 4;367(14):1355-60.
doi: 10.1056/NEJMsr1203730.
Authors
Roderick J Little
1
,
Ralph D'Agostino
,
Michael L Cohen
,
Kay Dickersin
,
Scott S Emerson
,
John T Farrar
,
Constantine Frangakis
,
Joseph W Hogan
,
Geert Molenberghs
,
Susan A Murphy
,
James D Neaton
,
Andrea Rotnitzky
,
Daniel Scharfstein
,
Weichung J Shih
,
Jay P Siegel
,
Hal Stern
Affiliation
1
Department of Biostatistics, University of Michigan, Ann Arbor, USA.
PMID:
23034025
PMCID:
PMC3771340
DOI:
10.1056/NEJMsr1203730
No abstract available
MeSH terms
Clinical Trials as Topic / standards*
Clinical Trials, Phase III as Topic / standards
Data Collection / standards
Intention to Treat Analysis
Research Design / standards*
Grants and funding
R01 AI102710/AI/NIAID NIH HHS/United States
P50 DA010075/DA/NIDA NIH HHS/United States
RC1 AA019186/AA/NIAAA NIH HHS/United States
P30 AI042853/AI/NIAID NIH HHS/United States
R01 MH080015/MH/NIMH NIH HHS/United States
P01 AA019072/AA/NIAAA NIH HHS/United States